First Interstate Bank Purchases 6,465 Shares of iShares Biotechnology ETF $IBB

First Interstate Bank boosted its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 18.7% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 41,082 shares of the financial services provider’s stock after acquiring an additional 6,465 shares during the period. First Interstate Bank’s holdings in iShares Biotechnology ETF were worth $6,937,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently bought and sold shares of IBB. Darwin Wealth Management LLC purchased a new position in iShares Biotechnology ETF during the 2nd quarter worth $25,000. Basepoint Wealth LLC acquired a new position in iShares Biotechnology ETF during the 4th quarter valued at about $26,000. Cary Street Partners Financial LLC purchased a new stake in iShares Biotechnology ETF in the fourth quarter valued at about $29,000. Copia Wealth Management purchased a new stake in iShares Biotechnology ETF in the fourth quarter valued at about $34,000. Finally, Caitlin John LLC acquired a new stake in iShares Biotechnology ETF in the fourth quarter worth about $34,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of NASDAQ IBB opened at $196.34 on Thursday. iShares Biotechnology ETF has a fifty-two week low of $128.84 and a fifty-two week high of $198.71. The business has a 50-day simple moving average of $174.77 and a two-hundred day simple moving average of $172.48.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Monday, June 15th were given a $0.0238 dividend. This represents a $0.10 annualized dividend and a dividend yield of 0.0%. The ex-dividend date of this dividend was Monday, June 15th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.